Edition:
United Kingdom

Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

42.85USD
16 Jul 2019
Change (% chg)

$0.10 (+0.23%)
Prev Close
$42.75
Open
$42.73
Day's High
$42.96
Day's Low
$42.49
Volume
4,741,785
Avg. Vol
6,641,030
52-wk High
$46.46
52-wk Low
$37.12

About

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business... (more)

Overall

Beta: 0.62
Market Cap(Mil.): $237,687.00
Shares Outstanding(Mil.): 5,559.93
Dividend: 0.36
Yield (%): 3.37

Financials

  PFE.N Industry Sector
P/E (TTM): 23.67 30.33 34.23
EPS (TTM): 1.81 -- --
ROI: 8.15 12.99 12.65
ROE: 16.55 14.18 17.19

Gilead invests $5 billion to deepen ties with biotech Galapagos

U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV , news that lifted Galapagos's shares more than 18% to an all-time high on Monday.

15 Jul 2019

Gilead invests $5 billion to deepen ties with biotech Galapagos

U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion (£4.1 billion) in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV , news that lifted Galapagos's shares more than 18% to an all-time high on Monday.

15 Jul 2019

UPDATE 4-Gilead invests $5 bln to deepen ties with biotech Galapagos

* Gilead makes $3.95 bln upfront payment, $1.1 equity investment

15 Jul 2019

GSK's HIV drug receives EU marketing nod

GlaxoSmithKline said its specialist HIV company had received marketing authorization from the European Commission for its drug to treat advanced stage HIV infections in adults and adolescents above the age of 12 and weighing at least 40 kg.

03 Jul 2019

GSK's HIV drug receives EU marketing nod

GlaxoSmithKline said its specialist HIV company had received marketing authorisation from the European Commission for its drug to treat advanced stage HIV infections in adults and adolescents above the age of 12 and weighing at least 40 kg.

03 Jul 2019

GSK's HIV drug receives EU marketing nod

July 3 GlaxoSmithKline said its specialist HIV company had received marketing authorisation from the European Commission for its drug to treat advanced stage HIV infections in adults and adolescents above the age of 12 and weighing at least 40 kg.

03 Jul 2019

Senator Warren asks former FDA chief Gottlieb to resign from Pfizer board

U.S. Senator Elizabeth Warren urged former U.S. Food and Drug Administration Commissioner Scott Gottlieb to immediately step down from Pfizer Inc's board, three months after his departure from the health regulator.

02 Jul 2019

Senator Warren asks former FDA chief Gottlieb to resign from Pfizer board

July 2 U.S. Senator Elizabeth Warren urged former U.S. Food and Drug Administration Commissioner Scott Gottlieb to immediately step down from Pfizer Inc's board, three months after his departure from the health regulator.

02 Jul 2019

Pfizer, Sanofi, to boost South African Biovac's vaccine output

CAPE TOWN South Africa's Biovac Institute will start local production of Sanofi's Hexaxim vaccine next year and Pfizer's anti-pneumonia Prevnar 13 vaccine in 2021, boosting supply of life-saving drugs in its main market, its CEO said.

02 Jul 2019

CORRECTED-Pfizer, Sanofi, to boost South African Biovac's vaccine output

CAPE TOWN, July 2 South Africa's Biovac Institute will start local production of Sanofi's Hexaxim vaccine next year and Pfizer's anti-pneumonia Prevnar 13 vaccine in 2021, boosting supply of life-saving drugs in its main market, its CEO said.

02 Jul 2019

Earnings vs. Estimates